Warning issued to company for using unfounded CBD treatment claims
FDA issues warning to a company that claimed its CBD products can be used to treat cancer and Alzheimer's disease.
List view / Grid view
FDA issues warning to a company that claimed its CBD products can be used to treat cancer and Alzheimer's disease.
The global downstream processing market is predicted to witness record-breaking growth due to a surge in the adoption of biotech processes.
New investment provides substantial new funding to fuel the next stage of Quotient’s growth.
A new report shows that there is still a lack of female representation within the senior roles of the major pharmaceutical companies.
The successful pilot programme could represent an important step forward in biopharmaceutical supply chain innovation.
The rise of diseases such as inflammatory bowel syndrome is projected to drive the global gastrointestinal drugs market in the upcoming years.
Vizimpro (dacomitinib) has been recommended as a first-line treatment option for patients with lung cancer.
A research group has designed a pills-on-a-coil system to administer drugs without having to take pills.
All sponsors of clinical trials conducted in the European Union have been reminded of their obligation to make summaries of trial results.
The price of over 3400 drugs have been hiked in the first half of 2019, surpassing the number of hikes imposed during the same period last year.
Macleods has issued a recall of 32 lots of drug products that contained trace amounts of NMBA impurities.
Pharmaceutical company, Pfizer, has announced it has completed the acquisition of Therachon for $340 million.
Former FDA Commissioner, Scott Gottlieb, who stepped down from the administration in April, has joined Pfizer’s board of directors.
Pharmaceutical company Pfizer was able to target the distribution of counterfeit Viagra in Hong Kong through serialisation technology.
AbbVie Inc. and Allergan plc have entered into a definitive transaction agreement under which AbbVie will acquire Allergan.